Newmedical

What Newmedical does

Newmedical Technology, Inc. is a privately held, vertically integrated medical device company founded in 2003 and headquartered in Northbrook, Illinois, that develops, manufactures, and distributes patented silicone-based scar therapies, advanced wound care dressings, and ergonomic surgical equipment across three product categories: Aesthetics (Silagen® professional scar therapy line sold exclusively through physician offices, MyNewGel+™ consumer silicone products, and BruiseMD™ nutritional supplement), Advanced Wound Care (DevraSorb™ loaded foam dressings cleared by FDA for 16 wound indications, including Ultra and Prime variants), and Surgical (UniTable™ carbon fiber, radiolucent, pneumatic surgical hand table). All products are manufactured in-house at an FDA-registered, ISO 13485:2003-certified, cGMP-compliant facility, and the company holds three granted patents covering wound irrigation, composite therapeutic-agent sheets, and transdermal delivery systems.

The company operates a dual-channel business model: a US direct sales force of approximately 30 professionals targets plastic surgeons, dermatologists, OB/GYNs, orthopedic surgeons, and other specialists, while international revenue flows through a validated distributor network spanning more than 30 countries across six continents (North America, EMEA, LATAM, Middle East, Asia Pacific, Oceania). Consumer-facing products (NewGel+) are sold through pharmacies, drug stores, hypermarkets, and online channels. Revenue mechanics are anchored in hardware/consumable product sales of 40+ SKUs, with the professional Silagen line carrying a physician-channel exclusivity model and the consumer line providing retail reach.

Growth has historically been funded organically — no funding rounds, institutional investors, or parent entities are disclosed — with management reporting "consistent double-digit growth year after year." Strategic expansion has occurred through targeted acquisitions (BruiseMD and DevraSorb in 2016; Derma Made in 2026), product line extensions (Silagen Gel + SPF 30, NewGel+UV, Lipolock), and international distribution buildout. Founder ownership remains intact, with A. Michael Hanna (Chairman & CEO) and Haitham Matloub (COO) co-founding the business in 2003 and continuing in active executive roles alongside a professionalized C-suite (CFO Dan DeSio ex-Abbott, CCO Martin Floreani ex-Merck/Stiefel).

Name

Newmedical

Legal name

Newmedical Technology, Inc.

Website

https://newmedical.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

51–100 employees

Short description

Newmedical Technology is a privately held, vertically integrated medical device company that develops and manufactures silicone-based scar therapies, advanced wound care dressings, and ergonomic surgical equipment, selling to specialty physicians (plastic surgeons, dermatologists, OB/GYNs), hospitals, and consumers across 30+ countries.

Ownership category

akta.pro rank

Product category

Medical Devices and Wound Care

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)

akta.pro secondary industries

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)

Keywords

• Medical wound care products
• Scar management therapies
• Silicone scar gels
• Advanced wound dressings
• Surgical ergonomic equipment

Headquarters

HQ city

Northbrook

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device and Product Sales: Newmedical generates revenue through the development, manufacturing, and distribution of patented medical products including advanced wound care dressings, scar management therapies, and surgical equipment. Products are sold through direct sales force to healthcare professionals and through distributor network internationally. Consumer products are sold through retail and online channels.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

Newmedical Technology, Inc. is a global medical products company that develops, manufactures, and distributes patented therapies across three product lines: Aesthetics (silicone-based scar management gels, sheeting and rapid recovery systems under the Silagen professional and NewGel+ consumer brands), Advanced Wound Care (DevraSorb loaded foam dressings and Lipolock), and Surgical (UniTable ergonomic surgical hand tables). The company sells its physician-exclusive Silagen line through authorized doctors, its NewGel+ consumer line through pharmacies and online, and distributes internationally through a validated network of distributors in 30+ countries.

Product overview

Newmedical Technology is a global medical products company offering a unified portfolio of patented therapies organized across three product lines: Aesthetics (scar management and bruise relief including Silagen professional line, MyNewGel+ consumer products, and BruiseMD), Advanced Wound Care (Devrasorb loaded foam dressings including Ultra and Prime variants, and Lipolock), and Surgical (Unitable Surgical Hand Table). The Silagen® Scar Refinement System is the physician-exclusive professional line while MyNewGel+ serves consumer/retail markets. The company manufactures all products in its own FDA-registered, ISO-certified facility and makes more than 40 products serving patients from c-section scars to chronic wounds of the elderly.

Differentiator

Problem solved

Functional benefit

Brands

• NewGel+: Consumer scar treatment product line including silicone gel sheeting and advanced silicone gel for scars.
• MyNewGel+
• Silagen
• DevraSorb
• BruiseMD
• UniTable

Products and services

• Silagen Scar Refinement System Comprehensive line of physician-exclusive, medical grade silicone scar therapies including silicone gels and sheeting for softening, flattening, and reducing scar redness, targeted at plastic surgeons and dermatologists.
• Silagen 100% Pure Silicone Gel Medical grade silicone gel with silky feel and fast drying time, physician-exclusive and preferred by 98% of physicians over leading professional scar gels.
• Silagen Silicone Gel + SPF 30 Medical grade silicone gel combined with zinc oxide mineral sunscreen to prevent UV-induced scar hyperpigmentation without chemical sunscreens.
• Silagen Silicone Gel Sheeting Silicone gel sheets available in 12 shapes and sizes designed for plastic surgeons and dermatologists, with advanced adhesion technology, washable, reusable and durable.
• Silagen Rapid Recovery System Post-procedural symptom relief system including Arnica Bromelain Complex Supplements and Topical Recovery Gel to reduce patient downtime following cosmetic and surgical procedures.
• MyNewGel+ Silicone Sheeting for Scars Medical grade silicone sheeting for consumer use, with better durability, adhesion, and variety of sizes and shapes to fit various scar types.
• MyNewGel+E Advanced Silicone Gel for Scars Consumer silicone gel that is invisible, odorless, easy to apply, and quick drying with a soft, silky feel for improving older scar appearance.
• BruiseMD All-natural nutritional supplement providing Arnica montana blossom and bromelain with grapeseed extract, vitamin C, zinc, rutin, and citrus bioflavonoids to reduce swelling and bruising related to surgery, cosmetic procedures, or injuries.
• DevraSorb Loaded foam dressing with superabsorbent polyurethane foam core that absorbs up to 15 times and retains up to 10 times its weight in fluids, cleared by FDA for 16 different wound indications.
• DevraSorb Ultra Advanced wound dressing with unique formulation for wounds with excessive drainage, providing 20% increase in absorptive capabilities over core DevraSorb product.
• DevraSorb Prime Primary layered foam dressing for deep wounds with DevraSorb core components in each layer; either side can be placed against wound bed without outer film.
• Lipolock Advanced wound care product designed for lipo-related procedures.
• UniTable Surgical Hand Table Innovative surgical hand table with pneumatic height adjustment, ergonomically designed contour for surgeon comfort, carbon fiber composite radiolucent tabletop, and single leg design minimizing floor clutter for microsurgical procedures.

Quantifiable outcome

• DevraSorb dressings absorb up to 15 times their weight in fluids and retain up to 10 times their weight
• +4 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• International Distributor PartnerscoreChannel Partner/ Reseller/ DistributorNewmedical has established global distribution alliances with validated, high-performance distributor partners across 30+ countries on 6 continents. Distributors have their own sales teams and established relationships in aesthetics, dermatology, plastic surgery, OB/GYN, and other surgical and wound care specialties. Countries include Argentina, Australia, Bahrain, Canada, Costa Rica, Czech Republic, Ecuador, Egypt, Germany, Greece, Hong Kong, India, Iraq, Israel, Italy, Jordan, Korea, Kuwait, Lebanon, Mauritius Island, Mexico, Netherlands, Norway, Oman, Pakistan, Palestine, Peru, Qatar, Saudi Arabia, Sweden, Taiwan, Turkey, UAE, UK, and others.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Mölnlycke Health Care: Mölnlycke is a global leader in wound care with Mepilex foam dressings that directly overlap with Newmedical's DevraSorb product family. Also serves burn centers and surgical specialties similar to Newmedical's advanced wound care customers.
• 3M Health Care (KCI): 3M's Health Care division (including the former KCI) offers a broad wound care portfolio including foam dressings and negative pressure wound therapy. Operates at significantly greater scale than Newmedical across the same hospital and wound clinic channels.
• Hollister Incorporated: Hollister is a privately held global medical products company with advanced wound care (Hollister Wound Care) and ostomy products. Competes with Newmedical's DevraSorb dressings in hospital and home healthcare channels, with similar FDA-cleared indications.
• ConvaTec: ConvaTec is a multinational wound and ostomy care company with Aquacel foam and gelling fiber dressings overlapping with DevraSorb. Competes for hospital, nursing home, and home healthcare wound care formulary slots with comparable indications to Newmedical's 16 cleared DevraSorb indications.
• Coloplast: Coloplast is a global wound care and specialty medical products company with Biatain foam dressings competing with DevraSorb. Strong presence in burn, chronic wound, and post-surgical care channels aligned with Newmedical's advanced wound care customers.
• Smith & Nephew: Smith & Nephew is a large multinational incumbent in advanced wound care (Allevyn, Acticoat, PICO) and scar management. Competes with Newmedical's DevraSorb foam dressings across hospitals and wound care clinics and offers silicone-based scar therapies overlapping with Silagen.

Direct peers

• ScarAway (Pacific World Corporation): ScarAway is a direct competitor in the consumer silicone scar treatment market, sold through pharmacies and online retailers similarly to NewGel+. Targets the same end consumer use cases (post-surgical, post-burn, post-trauma scars) with comparable silicone sheet and gel formats.
• Stratpharma: Stratpharma is a direct peer in advanced silicone-based scar management, offering products like Strataderm gel and Stratamed. Competes head-to-head with Silagen in the professional scar therapy category globally, with strong hospital and burn center presence.
• Biodermis: Biodermis is a direct competitor in medical-grade silicone scar therapy with its Pro-Sil and Epi-Derm silicone sheeting and gel products. Targets the same plastic surgeon, dermatologist, and OB/GYN channels as Silagen and NewGel+ with overlapping product formats and physician distribution model.
• Merz Aesthetics / Mederma: Mederma (Merz) is a leading consumer scar treatment brand directly competing with Newmedical's NewGel+ and MyNewGel+ OTC product lines in pharmacy and online channels. Operates with significantly larger consumer marketing budgets in the same scar gel category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Newmedical